CompletedNCT01881763
Ketamine Compared With Methohexital During ECT for Depression
About this title
Read the official source — NCT01881763Medication studyAges 18–70United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 70 years.
- Listed locations
- Glen OaksSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: June 2010
- Recruitment status
- Completed
- Enrollment listed in the registry
- 31
- Sponsor
- Northwell Health
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT01881763
- Official title
Show the full official title
Comparing Therapeutic Efficacy and Cognitive Side Effects of Electroconvulsive Therapy (ECT) Using Ketamine Versus Methohexital Anesthesia
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Glen Oaks
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Northwell Health.
Did this study involve medication?
Yes. The study involved medication, including ketamine and Methohexital.
Who was this study for?
Listed age limits: 18 years to 70 years.
